Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin

scientific article published on 01 July 2006

Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/BC050355D
P698PubMed publication ID16848407

P2093author name stringXin Zhang
Junhui Chen
Xinchang Wang
Yongjun Nie
P433issue4
P304page(s)995-999
P577publication date2006-07-01
P1433published inBioconjugate ChemistryQ2343023
P1476titlePreparation and stability of N-terminal mono-PEGylated recombinant human endostatin
P478volume17

Reverse relations

cites work (P2860)
Q28483340A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1
Q88180576A pre-clinical safety study of PEGylated recombinant human endostatin (M2ES) in Sprague Dawley rats
Q36485789Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
Q36220259Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.
Q26766481Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells
Q53538417Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.
Q101137934Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8
Q37790702Product development issues for PEGylated proteins
Q36237972Site-specific PEGylation of lidamycin and its antitumor activity
Q37689616Stability of protein pharmaceuticals: an update
Q37306704Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics

Search more.